Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719339 · ClinicalTrials.gov registry record
VIRTUUS Children's Study
A clinical trial of End Stage Renal Disease and Antibody-mediated Rejection, sponsored by Children's Hospital of Philadelphia.
- Active
- Registry status
- 445
- Enrollment target
- 13
- Study locations
NCT03719339: Active study of End Stage Renal Disease and Antibody-mediated Rejection, sponsored by Children's Hospital of Philadelphia.
NCT03719339 is a study of End Stage Renal Disease and Antibody-mediated Rejection that is active but no longer recruiting, run by Children's Hospital of Philadelphia. The registered enrollment target is 445 participants, below the 828-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (46% lower). The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03719339, a study of End Stage Renal Disease and Antibody-mediated Rejection, is active but no longer recruiting, sponsored by Children's Hospital of Philadelphia.
- ACTIVE NOT RECRUITING
- Registry status
- 445 participants
- Enrollment target
- 13
- Study locations
Study Summary
The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.
Primary Outcome
The amount of mRNA observed in urinary sample biopsy.
Conditions Studied
Study Locations (13)
California
- University of California-San Diego, Rady Children's Hospital - La Jolla
- Children's Hospital Los Angeles - Los Angeles
- University of California - Los Angeles
- Stanford University - Palo Alto
Pennsylvania
- CHOP - Philadelphia
- University of Pennsylvania - Philadelphia
District of Columbia
- Children's National Medical Center - Washington D.C.
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Minnesota
- University of Minnesota - Minneapolis
New York
- Joan & Sanford I. Weill Medical College of Cornelle University - New York
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2017-08-10 |
| Est. Completion | 2026-03-31 |
What the registry record for NCT03719339 still lists
NCT03719339 is an observational study that tracks outcomes without assigning an intervention. The registered 445 participants enrollment target is mid-sized for trials with a published cap, below the 828-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (46% lower).
The record links to 7 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03719339 lists 13 locations in 9 states (California, Pennsylvania, District of Columbia).
Frequently Asked Questions
What is clinical trial NCT03719339 about?
NCT03719339 is a clinical study titled "VIRTUUS Children's Study". The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.
What is the current status of trial NCT03719339?
This trial is currently active not recruiting. The enrollment target is 445 participants. The study started on 2017-08-10. Estimated completion is 2026-03-31.
What conditions does trial NCT03719339 study?
This clinical trial studies the following conditions: End Stage Renal Disease, Antibody-mediated Rejection, Nephropathy, Pediatric Kidney Disease, Renal Transplant Rejection.
Who is sponsoring clinical trial NCT03719339?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03719339 being conducted?
This trial has 13 study locations across California, District of Columbia, Illinois, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03719339's enrollment target sits among peer trials
445 13th of 86 higher than 74 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
RECRUITING
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
RECRUITING · Phase 1
-
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- NCT06348394 · 444 participants · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI